.
The PXRD, DSC and TG investigations indicate that the liquid-assisted grinding of NFX and fumaric acid in the 1:1 molar ratio leads to formation of two distinct products with the same drug/acid ratio but a different number of water molecules in the crystal lattice, which was calculated from the sample mass loss in the TG experiments ( Figure S1 and S2). As Table S1 shows, grinding the components with ACN, EtOH or MeOH or their mixtures with 5% water resulted in the formation of norfloxacin fumarate monohydrate (1:1:1) ( Figure S3a ). An increase in the mixture water content up to 50% or usage of pure water produces an alternative crystalline form of NFX fumarate which contains 2 molecules of water per 1 molecule of the salt ( Figure   S3a ). Considering the existence of the [CIP+Fum+H 2 O] (1:0.5:1.5) salt, where fumaric acid acts as a diprotic acid, NFX and fumaric acid were ground in the 1:0.5 molar ratio, which resulted in the isolation of the third solid form of the salt, later identified as norfloxacin hemifumarate monohydrate (1:0.5:1). The TG analysis of this form revealed the sample mass loss of 4.65% over the temperature range of 25-160C, which corresponds to 1 water molecule per 1.5 molecule of the salt ( Figure S4 ). It was found that the water content in a mixed solvent had no effect on the final product of the mechanochemical synthesis, in contrast to LAG experiments with 1:1 drug to acid ratio (Table 1 ).
In the case of ciprofloxacin, PXRD analysis has shown that grinding of the components in the presence of neat ACN, EtOH and MeOH or 5% water/organic mixtures leads to the formation of a product which differs from the known forms of salts in powder patterns, i.e. fumarate monohydrate and hemifumarate sesquihydrate ( Figure S3b ). In addition, the DSC curve of the new material has only one endotherm, corresponding to the melting process of the salt (227.8 ºC), while there is no evidence of a dehydration process ( Figure S5 ). Therefore, this form is considered to be an anhydrous salt of ciprofloxacin fumarate with 1:1 molar ratio, later referred to as [CIP+Fum] (1:1). Adding water or 50% water/organic mixtures to the reactants (CIP and fumaric acid) turns the mechanochemical reaction to the formation of either [CIP+Fum+H 2 O]
(1:1:1) or [CIP+Fum+H 2 O] (1:0.5:1.5), depending on the stoichiometry of the components (Table S1 , Figure S3b ). Since the crystal structures of these salts are known, the ground products were identified by comparing the experimental and calculated PXRD patterns ( Figure S6 ).
In order to evaluate the relative stability of the solid forms of ciprofloxacin and norfloxacin fumarates, the corresponding salts underwent mechanochemical treatment in the presence of different solvents (Table S2 ). At the next step, all the new phases were characterised by the single crystal X-ray diffraction.
Therefore, the bulk phase purity of the samples obtained in the LAG experiments was confirmed by comparing the experimental PXRD with the calculated lines from the X-ray crystal structures ( Figures S7, S8) . 
